Figure 6
Outcomes by FLT3-ITD allele burden. (A) Baseline FLT3-ITD mutation burden of responders vs nonresponders. (B) FLT3-ITD mutation burden of responders versus nonresponders at 1 to 3 months after treatment initiation.
Outcomes by FLT3-ITD allele burden. (A) Baseline FLT3-ITD mutation burden of responders vs nonresponders. (B) FLT3-ITD mutation burden of responders versus nonresponders at 1 to 3 months after treatment initiation.
